In vivo reprogramming drives Kras-induced cancer development-Reference-Cited by-同舟云学术

In vivo reprogramming drives Kras-induced cancer development

Published:2018-05-25 Issue:1 Volume:9 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Shibata Hirofumi,Komura Shingo,Yamada Yosuke,Sankoda Nao,Tanaka Akito,Ukai Tomoyo,Kabata Mio,Sakurai Satoko,Kuze Bunya,Woltjen Knut^ORCID,Haga Hironori,Ito Yatsuji,Kawaguchi Yoshiya,Yamamoto Takuya^ORCID,Yamada Yasuhiro

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-018-04449-5.pdf

Reference69 articles.

1. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676 (2006).

2. Okita, K., Ichisaka, T. & Yamanaka, S. Generation of germline-competent induced pluripotent stem cells. Nature 448, 313–317 (2007).

3. Wernig, M. et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448, 318–324 (2007).

4. Maherali, N. et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1, 55–70 (2007).

5. Polo, J. M. et al. A molecular roadmap of reprogramming somatic cells into iPS cells. Cell 151, 1617–1632 (2012).

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The E3 ubiquitin ligase TRIP12 is required for pancreatic acinar cell plasticity and pancreatic carcinogenesis;The Journal of Pathology;2024-06-25

2. In vivo targeted and deterministic single cell malignant transformation;2024-06-03

3. In vivo targeted and deterministic single cell malignant transformation;2024-06-03

4. Possible Strategies to Reduce the Tumorigenic Risk of Reprogrammed Normal and Cancer Cells;International Journal of Molecular Sciences;2024-05-09

5. Translational research in head and neck cancer: Molecular and immunological updates;Auris Nasus Larynx;2024-04